Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 2.2B | 2.7B | 2.6B | 2.4B |
Cost of revenue | 747.0M | 826.3M | 709.6M | 681.8M |
Gross profit | 1.4B | 1.9B | 1.9B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 104.6M | 143.0M | 141.1M | 89.7M |
Operating income | 1.3B | 1.7B | 1.7B | 1.6B |
Non operating interest income | ||||
Income | 30.1M | 36.2M | 40.7M | 36.5M |
Expense | 9.1M | 3.2M | 6.5M | 10.6M |
Other income expense | — | — | — | — |
Pretax income | 726.4M | 1.6B | 1.7B | 1.4B |
Tax provision | 1.0B | 1.4B | 1.3B | 1.2B |
Net income | -276.1M | 269.4M | 478.8M | 147.8M |
Basic EPS | -0.5 | 0.5 | 0.9 | 0.3 |
Diluted EPS | -0.5 | 0.5 | 0.9 | 0.3 |
Basic average shares | 538.2M | 538.6M | 538.4M | 537.6M |
Diluted average shares | 538.2M | 538.6M | 538.4M | 537.6M |
EBITDA | 1.1B | 2.0B | 2.5B | 1.9B |
Net income from continuing op. | 726.4M | 1.6B | 1.7B | 1.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |